Fundz

Cyclerion Therapeutics, Inc. reported raising $24.3 Million in an initial SEC Form D filing, from an offering of $24.3 Million

PUBLIC · KRSAAug 11, 2020

Amount Raised

$24.3 Million

$24.3 Million sold, per SEC Form D (first sale Aug 11, 2020)

Round Type

Venture

WalthamBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Korsana Biosciences raised $24.3 Million in a funding round, dated August 11, 2020. Korsana Biosciences is based in Waltham, Massachusetts, United States.

How much did Korsana Biosciences raise?
Korsana Biosciences raised $24.3 Million in a funding round on August 11, 2020.
What does Korsana Biosciences do?
Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease.
Where is Korsana Biosciences based and how big is it?
Korsana Biosciences is based in Waltham, Massachusetts, United States. Fundz records about 37 employees.
Who are the decision-makers at Korsana Biosciences?
Fundz holds 5 contacts at Korsana Biosciences, including the Head of Financial Planning & Analysis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Korsana Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Azora Therapeutics, Inc. (DE) raised $500K on September 25, 2020.
  • Vaccinex raised $2M (Seed) on September 16, 2020.
  • Recursion Pharmaceuticals raised $236M on September 15, 2020.
  • AEON Biopharma raised $25M on August 31, 2020.
  • TuHURA Biosciences raised $22M on August 27, 2020.
  • Jade Biosciences raised $76M on August 14, 2020.

Who to call at Korsana Biosciences, and when

A new round usually means Korsana Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Korsana Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Korsana Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Korsana Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Korsana Biosciences

Location

Waltham, Massachusetts, United States

About

Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease. The company leverages its proprietary THETA™ therapeutic targeting platform to improve drug delivery and efficacy. Founded in 2024, Korsana aims to elevate patient care by creating potentially best-in-class therapeutics. The company's lead program, KRSA-028, targets amyloid beta and demonstrates strong preclinical data.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Korsana Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

5 contacts
Verified contactsJuan P., Head of Financial Planning & Analysis hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Korsana Biosciences's next move

See what Strategic adds

Korsana Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.